How to Interpret a Positive ANA
| ANA Titre | Clinical Significance |
|---|---|
| 1:40 | Very common in healthy people: low significance alone |
| 1:80 | Borderline: consider clinical context |
| 1:160 | Clinically significant: warrants further investigation with ENA panel |
| ≥1:320 | Strongly positive: high probability of autoimmune disease |
ANA Pattern and Associated Diseases
| ANA Pattern | Associated Antibody | Condition |
|---|---|---|
| Homogeneous (diffuse) | Anti-dsDNA, anti-histone | SLE, drug-induced lupus |
| Speckled | Anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl70 | SLE, Sjögren's, scleroderma, MCTD |
| Nucleolar | Anti-Scl70, anti-PM-Scl | Systemic sclerosis |
| Centromere | Anti-centromere | Limited scleroderma (CREST) |
ENA Panel Follows Positive ANA
If ANA is positive at ≥1:160, an extractable nuclear antigen (ENA) panel is ordered: anti-dsDNA, anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl-70, anti-Jo-1, anti-centromere. These more specific antibodies guide diagnosis.
References
The clinical information on this page is based on peer-reviewed sources indexed in PubMed, the biomedical literature database of the US National Library of Medicine.
- Satoh M, Chan EKL, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64(7):2319-27. doi:10.1002/art.34380 · PMID 22354543
References
Sources cited on this page. PubMed links open the original abstract.
- Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124(1):71–81. PMID 12209511 · doi:10.5858/2000-124-0071-GFCUOT
Related reading
- Guide to Autoimmune Blood TestsWhat blood tests diagnose autoimmune diseases? Learn about ANA…
- Lupus (SLE): Diagnosis & Treatment GuideComplete guide to systemic lupus erythematosus: symptoms, diagnostic…
- Rheumatoid Factor (RF) Blood TestWhat does a positive rheumatoid factor (RF) blood test mean? Normal…
- Anti-CCP & Rheumatoid Factor: Rheumatoid Arthritis TestsAnti-CCP and rheumatoid factor are the key blood tests for diagnosing…
- Widal TestWhat does a positive Widal test mean? Understand Widal test titres…
- Multiple Sclerosis (MS)What blood tests are done for multiple sclerosis? Learn how MS is…
A positive ANA is common in healthy people
This is the single most important thing to understand about the test. Depending on the cut-off used, roughly 10 to 15 per cent of entirely healthy people have a positive ANA at 1:80, and the proportion rises with age and is higher in women. A positive result in someone without symptoms therefore has a low probability of indicating disease. This is why the test performs badly as a screen and why guidelines discourage ordering it in the absence of clinical features suggesting connective tissue disease.
The corollary matters too: because so many well people test positive, an unexplained positive ANA frequently causes considerable anxiety and leads to further testing that finds nothing. Where a result has already been obtained without a clear indication, the sensible interpretation is to weigh it against the clinical picture rather than to pursue it in isolation.
Titre changes what the result means
- 1:40 to 1:80 is weakly positive and frequently seen in healthy individuals.
- 1:160 is moderately positive and warrants correlation with symptoms.
- 1:320 and above is more likely to be clinically significant, particularly with a defined pattern.
Titres are reported as doubling dilutions, so each step represents a twofold change. A shift from 1:160 to 1:320 is one dilution and may reflect assay variation rather than disease activity, which is why ANA titres are not used to monitor established disease.
What follows a meaningful positive
Where the clinical picture supports it, the next step is specific antibody testing rather than repeating the ANA: anti-dsDNA and anti-Sm for lupus, anti-Ro and anti-La for Sjögren's, anti-centromere and anti-Scl-70 for systemic sclerosis, anti-Jo-1 for myositis. Complement levels, urinalysis for protein and blood, and a full blood count are usually checked at the same time, since organ involvement matters more than serology. A negative ANA makes lupus unlikely but does not exclude every connective tissue disease, and some conditions are ANA-negative by nature.